Serkan Levent

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 24

Top Topics

Molecular Docking

Cognitive Decline

Early Breast Cancer

Structure Activity Relationship

Top Venues

Molecules (Basel, Switzerland)

Archiv der Pharmazie

Chemical biology & drug design

Journal of enzyme inhibition and medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Sazan Haji Ali, Derya Osmaniye, Begüm Nurpelin Sağlık, Serkan Levent, Yusuf Özkay, Zafer Asım Kaplancıklı
Design, synthesis, and molecular docking studies of novel quinoxaline derivatives as anticancer agents. Chemical biology & drug design (2023)
Neslihan Conger, Derya Osmani Ye, Begüm Nurpelin Sağlık Özkan, Serkan Levent, Yusuf Özkay, Zafer Asım Kaplancıklı
Design, synthesis, biological activities, and evaluation of molecular docking-dynamics studies of new thiosemicarbazones that may be effective against Alzheimer's disease. Journal of molecular recognition : JMR (2023)
Sazan Haji Ali, Derya Osmaniye, Begüm Nurpelin Sağlık, Serkan Levent, Yusuf Özkay, Zafer Asım Kaplancıklı
Design, synthesis, and molecular docking studies of novel quinoxaline derivatives as anticancer agents. Chemical biology & drug design (2023)
Sazan Haji Ali, Derya Osmaniye, Begüm Nurpelin Sağlık, Serkan Levent, Yusuf Özkay, Zafer Asım Kaplancıklı
Design, synthesis, and molecular docking studies of novel quinoxaline derivatives as anticancer agents. Chemical biology & drug design (2023)
Aysun Geven, Saniye Özcan, Serkan Levent, Nafiz Öncü Can
A Different Perspective on the Characterization of a New Degradation Product of Flibanserin with HPLC-DAD-ESI-IT-TOF-MSn and its Pharmaceutical Formulation Analysis with Inter-Laboratory Comparison. Journal of AOAC International (2023)
Derya Osmani Ye, Iqrar Ahmad Ansari, Begüm Nurpelin Sağlık Özkan, Serkan Levent, Harun M Patel, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, synthesis and molecular docking and ADME studies of novel hydrazone derivatives for AChE inhibitory, BBB permeability and antioxidant effects. Journal of biomolecular structure & dynamics (2022)
Sazan Haji Ali, Derya Osmani Ye, Begüm Nurpelin Sağlık Özkan, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, Synthesis, and Evaluation of Novel 2 H -Benzo[b][1,4]thiazin-3(4 H )-one Derivatives as New Acetylcholinesterase Inhibitors. Molecules (Basel, Switzerland) 27 (7) (2022)
Begüm Nurpelin Sağlık Özkan, Derya Osmani Ye, Ulviye Acar Çevik, Serkan Levent, Betül Kaya Çavuşoğlu, Ozlem Atli-Eklioglu, Özlem Atlı Eklioğlu, Ali Savaş Koparal, Zafer Asım Kaplancıklı
Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Derya Osmani Ye, Berkant Kurban, Begüm Nurpelin Sağlık Özkan, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors. Molecules (Basel, Switzerland) 26 (21) (2021)
Derya Osmani Ye, Asaf E Evren, Begüm N Sağlık, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors. Archiv der Pharmazie 355 (3) (2021)
İlçim Ceyhun, Şevval Karaca, Derya Osmani Ye, Begüm Nurpelin Sağlık Özkan, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase. Archiv der Pharmazie (2021)
Ulviye Acar Çevik, Begüm Nurpelin Sağlık Özkan, Derya Osmani Ye, Serkan Levent, Betül Kaya Çavuşoğlu, Abdullah Burak Karaduman, Ozlem Atli-Eklioglu, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Betül Kaya Çavuşoğlu, Begüm Nurpelin Sağlık Özkan, Ulviye Acar Çevik, Derya Osmani Ye, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX-2 inhibitors. Archiv der Pharmazie 354 (3) (2020)
Begüm Nurpelin Sağlık Özkan, Betül Kaya Çavuşoğlu, Ulviye Acar Çevik, Derya Osmani Ye, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors - design, synthesis, biological evaluation and molecular modelling. RSC medicinal chemistry 11 (9) (2020)
Begüm Nurpelin Sağlık Özkan, Derya Osmaniye, Ulviye Acar Çevik, Serkan Levent, Betül Kaya Çavuşoğlu, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, Synthesis, and Structure-Activity Relationships of Thiazole Analogs as Anticholinesterase Agents for Alzheimer's Disease. Molecules (Basel, Switzerland) 25 (18) (2020)
Begüm Nurpelin Sağlık Özkan, Osman Cebeci, Ulviye Acar Çevik, Derya Osmaniye, Serkan Levent, Betül Kaya Çavuşoğlu, Sinem Ilgın, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors. Molecules (Basel, Switzerland) 25 (18) (2020)
Mehtap TuĞrak, Halise Inci Gul, Malihe Moradzadeh, Serkan Levent, İlhami Gulçin
Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone-based benzenesulfonamides. Archiv der Pharmazie 354 (4) (2020)
François Damen, James D Simo Mpetga, Olive Monique F Demgne, İlhami Çelik, Brice E N Wamba, Leon A Tapondjou, Veronique P Beng, Serkan Levent, Victor Kuete, Mathieu Tene
Roeperone A, a new tetraoxygenated xanthone and other compounds from the leaves of Hypericum roeperianum Schimp. (Hypericaceae). Natural product research (2020)
Ulviye Acar Çevik, Betül Kaya Çavuşoğlu, Begüm Nurpelin Sağlık, Derya Osmaniye, Serkan Levent, Sinem Ilgın, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor. Molecules (Basel, Switzerland) 25 (7) (2020)
Ulviye Acar Çevik, Begüm N Sağlık, Derya Osmaniye, Serkan Levent, Betül Kaya Çavuşoğlu, Abdullah B Karaduman, Özlem Atlı Eklioğlu, Zafer A Kaplancıklı
Synthesis and docking study of benzimidazole-triazolothiadiazine hybrids as aromatase inhibitors. Archiv der Pharmazie 353 (5) (2020)
Derya Osmaniye, Begüm Nurpelin Sağlık, Ulviye Acar Çevik, Serkan Levent, Betül Kaya Çavuşoğlu, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı, Gülhan Turan
Synthesis and AChE Inhibitory Activity of Novel Thiazolylhydrazone Derivatives. Molecules (Basel, Switzerland) 24 (13) (2019)
Ahmet Çağrı Karaburun, Betül Kaya Çavuşoğlu, Ulviye Acar Çevik, Derya Osmaniye, Begüm Nurpelin Sağlık, Serkan Levent, Özlem Atlı Eklioğlu, Özlem Atlı, Ali Savaş Koparal, Zafer Asım Kaplancıklı
Synthesis and Antifungal Potential of Some Novel Benzimidazole-1,3,4-Oxadiazole Compounds. Molecules (Basel, Switzerland) 24 (1) (2019)
Ulviye Acar Cevik, Begüm Nurpelin Saglik, Serkan Levent, Derya Osmaniye, Betul Kaya Cavuşoglu, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis and AChE-Inhibitory Activity of New Benzimidazole Derivatives. Molecules (Basel, Switzerland) 24 (5) (2019)
Ahmet Çağrı Karaburun, Ulviye Acar Çevik, Derya Osmaniye, Begüm Nurpelin Sağlık, Betül Kaya Çavuşoğlu, Serkan Levent, Yusuf Özkay, Ali Savaş Koparal, Mustafa Behçet, Zafer Asım Kaplancıklı
Synthesis and Evaluation of New 1,3,4-Thiadiazole Derivatives as Potent Antifungal Agents. Molecules (Basel, Switzerland) 23 (12) (2018)